Pazopanib as a second-line treatment for non-cytokine-treated metastatic renal cell carcinoma: a meta-analysis of the effect of treatment

Peer Review reports

Original Submission
21 Oct 2015	Submitted	Original manuscript
4 Nov 2015	Reviewed	Reviewer Report - Filippo Maria Turri
16 Nov 2015	Reviewed	Reviewer Report - Aditya Bagrodia
20 Nov 2015	Reviewed	Reviewer Report - Scott Delacroix
28 Nov 2015	Author responded	Author comments - Victor Kok
Resubmission - Version 2
28 Nov 2015	Submitted	Manuscript version 2
Publishing
16 Jun 2016	Editorially accepted
4 Jul 2016	Article published	10.1186/s12894-016-0156-4

Back to article page